The Campaign for Affordable Medicine: A Strategist’s Guide to Cutting Prescription Costs

Part 1: The Myth of the Savvy Shopper: Why Standard Advice Fails

Introduction – My Mother, a Prescription, and the Moment Everything Changed

The phone call came on a Tuesday.

It was my mother, her voice a mixture of stoicism and fear.

She’d just left her doctor’s office with a new diagnosis for a chronic autoimmune condition.

Then came the second blow.

When she went to the pharmacy, the pharmacist told her the monthly co-pay for her new, brand-name medication would be over $800.

“I can’t do that,” she said, her voice finally cracking.

“I just can’t.”

As a health policy researcher, I’ve spent over a decade studying the labyrinthine U.S. healthcare system.

I’ve written papers on drug pricing, analyzed insurance formularies, and advised on patient access issues.

My initial reaction was one of confidence, maybe even a little arrogance.

“Don’t worry, Mom,” I said.

“I study this for a living.

I can fix this.”

I was wrong.

For the next two weeks, I threw every piece of standard advice at the problem.

I told her to ask for a generic (none existed).

I spent hours online comparing pharmacy prices, only to find negligible differences.

I looked into discount cards.

I felt the confident expert in me slowly replaced by a frustrated, powerless son.

The system I understood academically was proving impenetrable in practice.

That frustrating journey, however, led to a critical realization: we were using the wrong map.

We were acting like shoppers in a market that was never designed for consumers.

To win, we had to stop shopping and start strategizing.

This guide is the result of that battle—a new playbook for navigating a system that feels designed to defeat you.

The Checklist of Frustration: Deconstructing Well-Intentioned but Flawed Advice

Millions of Americans are handed a checklist of well-intentioned but ultimately inadequate advice for lowering their prescription costs.

If you’ve tried these and failed, you are not alone.

The problem isn’t your effort; it’s that these tactics are designed for a different, simpler game.

They fail because the U.S. prescription drug system is not a consumer market; it is a complex, adversarial landscape where prices are artificially inflated and access is tightly controlled.

• “Just Ask for a Generic”: This is the first, most common piece of advice.¹ It’s excellent counsel when a generic equivalent is available. However, it’s completely ineffective for the very drugs that cause the most financial pain: new, innovative medications for conditions like cancer, autoimmune diseases, or rare disorders that are still protected by patents. In 2023, the median annual price for new drugs launched was a staggering $300,000, a 35% increase from the prior year.⁴ For patients like my mother who need these specific treatments, there is no generic alternative to ask for.
• “Shop Around for Better Prices”: This advice presumes a free-market dynamic where retailers compete on price.¹ But for anyone with insurance, the price you pay is primarily dictated by your insurer’s formulary (its list of covered drugs) and its network pharmacy agreements.² The cash price may vary slightly from pharmacy to pharmacy, but your co-pay for a covered drug is often fixed within your plan’s network. This tactic is largely irrelevant for the insured patient facing a high-cost specialty drug.
• “Use a Prescription Discount Card”: Services like GoodRx, SingleCare, and others are heavily advertised as a simple solution.⁶ These cards operate by negotiating cash prices with pharmacies and their partners, and they can offer substantial savings over the retail price.⁸ However, they come with a critical, often misunderstood flaw: they are used
  instead of your insurance, not with it. This means any money you spend using a discount card does not count toward your annual deductible or your out-of-pocket maximum.⁹ For a patient with a chronic condition who will inevitably hit their maximum, using a discount card can be a costly mistake, delaying the point at which their insurance begins to cover 100% of costs. Furthermore, since these companies are often not bound by HIPAA, they may be legally allowed to sell your personal health data.⁹
• “Get a 90-Day Supply”: Switching to a mail-order or 90-day retail supply can reduce the number of co-pays you make per year, which is a helpful savings strategy for affordable maintenance medications.¹ But this doesn’t change the underlying price of the drug. If a 30-day supply at $800 is unaffordable, a 90-day supply at $2,400 is impossible. This advice offers no help when the core problem is a denial of coverage or an exorbitant co-pay.

This standard advice fails because it fundamentally misdiagnoses the problem.

The struggle to afford medicine in the U.S. is not a shopping problem; it is a systemic problem.

The U.S. pays far more for drugs than any other high-income country—nearly 2.78 times as much as comparable nations in 2022.¹⁰

This is a direct result of a system where manufacturers can set prices without government regulation or negotiation, a practice banned in most of the developed world.¹²

The consequences are devastating.

Nearly one in three Americans reports not taking their medication as prescribed because of the cost, a decision that can lead to worsening health, hospitalization, and, for an estimated 1.1 million Medicare patients over the next decade, even death.⁴

The advice fails because it asks you to be a better shopper in a system that is rigged against you.

To succeed, you must adopt a new mindset.

Mindset	Goal	Key Tactics	Primary Limitation / Strength
The Shopper	Find the lowest retail price today.	Comparing pharmacy cash prices, using discount cards, asking for generics.	Limitation: Ignores the power of the insurer and manufacturer. Payments may not count toward deductible. Ineffective for high-cost, non-generic drugs.
The Strategist	Secure sustainable, long-term access to necessary medication at the lowest possible out-of-pocket cost.	Mastering insurance appeals, leveraging Patient Assistance Programs, using retail tactics selectively and with purpose.	Strength: Directly confronts the real gatekeepers (insurers, manufacturers) and provides a comprehensive plan for all scenarios, including the most expensive drugs.

Part 2: The Epiphany: From Consumer to Campaign Manager

A New Mental Model – Your Three-Front Campaign

After weeks of dead ends trying to solve my mother’s prescription problem, the epiphany came not from a research paper, but from sheer frustration.

I realized I was approaching the problem all wrong.

I wasn’t a consumer looking for a deal.

I was a soldier fighting a war.

This wasn’t a shopping trip; it was a campaign.

This mental shift changes everything.

It transforms you from a passive victim of the system into an active, empowered strategist.

The chaos of co-pays, denials, and paperwork suddenly organizes itself into a clear structure.

Think of securing affordable medicine as a strategic campaign fought on three distinct fronts:

1. The Insurance Front: This is your battle with your health insurance company. The objective is to get your medication covered under your plan at the lowest possible tier and co-pay. The adversaries are complex formularies, prior authorizations, and coverage denials.
2. The Manufacturer Front: This is your engagement with the pharmaceutical company that makes the drug. The objective is to gain access to their Patient Assistance Program (PAP) to receive the medication for free or at a very low cost. This front is typically engaged when the Insurance Front is lost or is not an option (e.g., for the uninsured).
3. The Retail Front: This is your interaction with the pharmacy and the cash-price market. The objective is to use tools like discount cards or online pharmacies tactically when other fronts have failed or are inappropriate. This is a battlefield of last resort or for specific, targeted situations.

Each front has a different adversary, different rules of engagement, and requires a completely different set of tactics.

Using a retail tactic (like a discount card) to fight an insurance battle (a coverage denial) is like bringing a knife to a gunfight—it’s the wrong tool for the job and destined to fail.

Understanding which front you are on is the first and most critical step to victory.

Part 3: Executing the Campaign: A Front-by-Front Playbook

Front 1: Mastering the Insurance Battlefield

This is where the most complex and high-stakes battles are fought.

Winning on the insurance front means your medication is covered by your plan, and every dollar you spend on co-pays counts toward your annual deductible and out-of-pocket maximum.

This is the foundation of sustainable access for anyone with insurance.

Decoding the Battlefield – Formularies, Tiers, and Step Therapy

Before you can fight, you must understand the terrain.

Your insurer’s primary weapons for controlling costs are the formulary, drug tiers, and step therapy.

• Formulary: This is simply the list of prescription drugs your insurance plan has agreed to cover.³ If a drug is not on the formulary, you will likely have to pay the full retail price.
• Tiers: The formulary is organized into price categories called tiers. Tier 1 drugs are typically preferred generics and have the lowest co-pay. Higher tiers (Tier 3, 4, or 5/Specialty) contain more expensive brand-name or specialty drugs and come with much higher co-pays or coinsurance.² Your goal is to get your drug covered on the lowest possible tier.
• Step Therapy: This is a common insurance policy that requires you to try and “fail” on one or more lower-cost drugs (the “preferred” options) before the plan will approve coverage for a more expensive medication.² Many initial denials are because a step therapy protocol was not followed. For example, a patient with chronic leukemia was denied his life-saving medication because the insurer wanted him to first try and fail on a cheaper alternative, despite his history of adverse reactions.¹⁶

The Prior Authorization (PA) Offensive

A Prior Authorization (PA) is a process where your doctor must get pre-approval from your insurer before they will cover a specific medication.¹⁷

Insurers use PAs to ensure a drug is medically necessary and to control costs, especially for expensive or specialty drugs.¹⁸

This is often the first hurdle you will face.

Your PA Action Plan:

1. Anticipate the Need: When your doctor prescribes a new, non-generic drug, ask them directly: “Will this medication require a prior authorization from my insurance?”
2. Partner with Your Doctor’s Office: The PA request is submitted by your provider. You can be an effective partner by providing them with the correct insurance information and being politely persistent. Understand that this process creates a significant administrative burden for them, too.¹⁹
3. Follow Up Systematically: The PA process can take anywhere from a few days to several weeks, and it can be delayed by simple paperwork errors.¹⁸ Call your insurer and your doctor’s office to check on the status. Many providers now use electronic PA services like CoverMyMeds to streamline submissions.²⁰

Winning the Appeal – Your Guide to Overturning a Denial

If your PA is denied, do not give up.

This is the moment you transition from patient to advocate.

The data reveals a shocking truth: while insurers deny millions of claims each year, fewer than 1% of consumers ever appeal those denials.¹⁶

This is a tragic mistake, because when patients

do appeal, the original decision is overturned in their favor between 44% and 60% of the time.¹⁶

The system, in many ways, relies on you to get frustrated and quit.

Persistence is your most powerful weapon.

Your Step-by-Step Appeal Process:

1. Analyze the Denial Letter: Your insurer is required to tell you why they denied the claim.²³ Was it because you didn’t complete step therapy? Was it deemed “not medically necessary”? Was there a paperwork error? The reason for the denial dictates your appeal strategy.²⁴
2. Launch the Internal Appeal: This is your first formal step, a request asking your insurance company to conduct a full and fair review of its decision.²² You will need to submit a formal letter. In it, include your name, policy number, and claim number. State clearly why you are appealing the decision and why the drug is medically necessary for your condition.²⁴
3. Gather Your Arsenal: Your appeal is only as strong as your evidence. Work with your doctor to assemble a compelling case file. This should include:

• A Letter of Medical Necessity from your doctor explaining why this specific drug is needed for your treatment.
• Relevant pages from your medical records.
• Peer-reviewed scientific articles or clinical guidelines that support the use of the medication for your condition.¹⁶

4. Escalate to an External Review: If your internal appeal is denied, you have the right to take your case to an independent, third-party review organization (IRO).²³ At this stage, the insurance company no longer gets the final say. The IRO’s decision is binding. This is a powerful and vastly underutilized consumer protection right.

Front 2: Engaging the Manufacturer

This front is your fallback position.

You engage the manufacturer when your insurance denies coverage and the appeal fails, or if you are uninsured or underinsured.

The goal here is to access a Patient Assistance Program (PAP).

The Ultimate Lifeline – Patient Assistance Programs (PAPs)

PAPs are programs run by pharmaceutical companies that provide their medications for free or at a very low cost to eligible individuals who cannot afford them.²⁶

These programs exist because the high list prices of drugs create significant access and public relations problems for the manufacturers themselves.¹³

For many patients, PAPs are the only way to access life-saving treatments.

Navigating the PAP Application Maze

Applying to a PAP can feel like applying for a loan—it requires documentation and attention to detail.

Success hinges on meeting the specific eligibility criteria.

Key Eligibility Hurdles:

1. Income: Eligibility is almost always tied to your annual household income, measured as a percentage of the Federal Poverty Level (FPL). For example, the Novo Nordisk PAP requires an income at or below 400% of the FPL.²⁶
2. Insurance Status: This is the most complex rule. PAPs are generally designed for patients who are uninsured or have government insurance like Medicare.²⁶ Crucially, many PAPs
   explicitly exclude patients with private or commercial insurance. Some commercial plans have even tried to create “alternate funding programs” that force their members to apply to PAPs, a practice that manufacturers like AbbVie now actively reject, making those patients ineligible for assistance.²⁸
3. Residency: You must be a U.S. citizen or legal resident.²⁶

The Application Process:

1. Identify the Program: Go to the drug manufacturer’s website and search for “Patient Assistance Program” or the drug name plus “assistance.”
2. Complete the Application: Download the application form. You will fill out the patient section, and your doctor must complete the prescriber section.²⁶
3. Gather Your Documents: You will need to provide proof of income (like a tax return or recent pay stubs) and sometimes proof of residency. Patients with Medicare Part D may need to provide a letter showing they were denied for the “Extra Help” program.²⁶
4. Submit and Follow Up: The completed application, with your doctor’s signature, is usually faxed directly from your doctor’s office. Processing can take a couple of business days to a few weeks. Follow up to ensure it was received and is being processed.²⁶

Manufacturer	Sample Drugs/Conditions	Income Limit (Typical)	Insurance Requirements	Key Application Notes
Novo Nordisk 26	Diabetes (various insulins)	≤ 400% of FPL	Must have Medicare or no insurance. Not eligible if you have private/commercial insurance.	Requires proof of income (e.g., tax return, pay stubs). Faxes must come from the provider’s office.
GSK 27	Respiratory, HIV, others	Varies by household size (e.g., ≤$28,800 for 1 person)	Must have no prescription drug benefits. Not eligible for Medicaid, VA, etc. (Medicare is an exception).	Patients can enroll themselves by mail/fax. Re-enrollment is required every 12 months.
AbbVie 28	Immunology (e.g., Humira), Oncology	Based on “qualifying financial need.”	Must have limited or no health insurance. Not eligible if your commercial plan requires you to apply (alternate funding programs).	Medicare Part D patients may need proof of denial from the Low Income Subsidy (LIS) program.

Front 3: Tactics for the Pharmacy & Retail Landscape

This front involves cash-based strategies that function outside of your insurance plan.

These are tactical tools to be used with caution and awareness of their limitations, not a replacement for a comprehensive strategy on the insurance and manufacturer fronts.

The Truth About Prescription Discount Cards

Prescription discount cards are essentially marketing programs.

They partner with Pharmacy Benefit Managers (PBMs) to create a network and negotiate lower cash prices on medications.

When you use their coupon, the pharmacy pays the discount card company a small referral fee.⁸

• When to Use Them: They can be very useful for the uninsured or for medications that are not covered by your insurance plan at all.
• When to Be Cautious: Always compare the discount card price to what your insurance co-pay would be.⁸ The co-pay is often cheaper. Most importantly, remember the
  Deductible Trap: money spent using a discount card does not accumulate toward your insurance deductible.⁹ For someone with high medical costs, this is a critical disadvantage.

The Online Pharmacy Dilemma – Convenience vs. Catastrophe

Buying medicine online offers convenience, but it is a landscape fraught with danger.

The FDA warns that many online pharmacies are unsafe, selling counterfeit, expired, or unapproved drugs.²⁹

According to the National Association of Boards of Pharmacy (NABP), a staggering 96% of websites selling prescription drugs operate illegally and out of compliance with U.S. law and safety standards.³⁰

To navigate this safely, you must be able to distinguish a legitimate pharmacy from a rogue one.

Safe Online Pharmacy Checklist

[ ] Requires a valid prescription from my doctor. 29

[ ] Is licensed by my state’s board of pharmacy (I have verified this on the state board’s official website). 29

[ ] Provides a verifiable physical U.S. address and telephone number. 32

[ ] Has a state-licensed pharmacist available to answer my questions. 33

[ ] Is NOT on the NABP’s “Not Recommended” list of websites. 30

The “Canadian Pharmacy” Myth

Many Americans believe that buying from an online pharmacy with a Canadian flag on its website is a safe and legal way to access cheaper medicine.

This is a dangerous misconception.

The NABP has conducted extensive reviews and found that U.S. consumers who buy from these sites rarely, if ever, receive drugs that are actually approved by Health Canada.

Instead, these “Canadian” storefronts often act as fronts for drop-shipping operations that source unapproved medications from unregulated facilities in countries like India, Turkey, or Southeast Asia.³¹

This is not a safe loophole; it is a gamble with your health.

Part 4: Global Context and Your Final Blueprint

Why Is This So Hard? A Look Abroad

If this three-front campaign sounds exhausting, it’s because it Is. And it’s a uniquely American burden.

The reason this strategic approach is necessary in the U.S. is because the American system is an international outlier in how it handles prescription drug costs.¹¹

In most other developed nations, the government acts as a central negotiator and regulator, creating a simpler, more predictable, and more affordable system for patients.

• United Kingdom: In England, most patients pay a flat prescription charge of £9.65 per item. Many people are exempt from this charge entirely, including children, seniors over 60, and individuals with specific long-term conditions like cancer or diabetes. While this charge can still be a barrier for some, it eliminates the catastrophic costs seen in the U.S..³⁵
• Australia: The government heavily subsidizes medicines through its Pharmaceutical Benefits Scheme (PBS). Patients pay a fixed co-payment, which in 2024 was a maximum of $31.60 for general patients. Furthermore, a “Safety Net” caps the total amount a family has to spend on PBS medicines each year. Once they reach the cap, their co-payments drop dramatically or become free for the rest of the year.³⁷
• New Zealand: Similar to Australia, New Zealand has a co-payment system, with most people paying a standard $5 per prescription item. The government’s drug-buying agency, PHARMAC, is renowned for its tough negotiations with drug companies to secure some of the lowest prices in the developed world.³⁹

The “Campaign Manager” role is a necessity born from a system that has largely offloaded the fundamental responsibilities of price regulation and access management onto its sickest citizens.

Country	Primary Cost Mechanism	Typical Patient Cost	Key Safety Net / Feature
United States	Privately negotiated prices between insurers and manufacturers; high deductibles and co-insurance.	Varies dramatically; can be thousands of dollars per month. 4	Patchwork of Patient Assistance Programs; out-of-pocket maximums.
United Kingdom	National Health Service (NHS) with a flat prescription charge in England.	£9.65 per item; free in Scotland, Wales, and Northern Ireland. 35	Widespread exemptions for age, income, and chronic conditions.
Australia	Government-subsidized Pharmaceutical Benefits Scheme (PBS).	Fixed co-payment (e.g., $31.60 in 2024). 37	Annual “Safety Net” cap on total family spending.
New Zealand	Government-negotiated prices via PHARMAC; patient co-payment.	$5 per item. 39	Annual 20-item cap per family, after which prescriptions are free.

Conclusion – Your Campaign Blueprint for a Healthier, More Affordable Future

Let me return to my mother’s story.

After failing with the standard advice, we adopted the campaign mindset.

We fought on the insurance front first, submitting a prior authorization that was, predictably, denied.

We then launched a formal internal appeal, armed with a powerful letter of medical necessity from her rheumatologist.

That, too, was denied.

But we didn’t stop.

We prepared for an external review, but simultaneously opened a second front: the manufacturer.

We found the Patient Assistance Program for her medication, filled out the exhaustive paperwork, and submitted her financial information.

Two weeks later, a letter arrived.

She was approved.

A 90-day supply of her $800-a-month medication would be shipped to her home, completely free of charge.

The relief was immense.

We had won, not by being savvy shoppers, but by being relentless strategists.

The system is daunting, complex, and often feels profoundly unfair.

But it is not unbeatable.

By shifting your mindset from that of a passive consumer to an active campaign manager, you can reclaim a measure of control.

Your blueprint is clear:

1. Assess the Battlefield: Identify which front you are on—Insurance, Manufacturer, or Retail.
2. Fight on the Insurance Front First: Use the prior authorization and appeals process to secure coverage that counts toward your deductible. Be persistent.
3. Open the Manufacturer Front as a Fallback: If insurance fails or is not an option, apply for Patient Assistance Programs.
4. Use the Retail Front Tactically: Use discount cards and safe online pharmacies only when you understand their limitations and it makes strategic sense for your situation.

This is more than a list of tips; it is a framework for advocacy.

It is a way to turn frustration into action, and action into access.

The fight is hard, but your health is worth it.

Works cited

1. 6 Real Ways to Save Money on Prescriptions – GuideStone, accessed August 14, 2025, https://www.guidestone.org/Resources/Education/Articles/Insurance/6-Real-Ways-to-Save-Money-on-Prescriptions
2. Saving money on prescription drugs as a health care consumer …, accessed August 14, 2025, https://www.fidelity.com/viewpoints/personal-finance/how-to-save-money-on-prescription-drugs
3. 7 easy ways to help pay less for your prescriptions | News & articles – United Healthcare, accessed August 14, 2025, https://www.uhc.com/news-articles/healthy-living/7-easy-ways-to-help-pay-less-for-your-prescriptions
4. Drug Prices and Shortages Jeopardize Patient Access to Quality Hospital Care | AHA News, accessed August 14, 2025, https://www.aha.org/news/blog/2024-05-22-drug-prices-and-shortages-jeopardize-patient-access-quality-hospital-care
5. Do You Know How to Save Money on Prescription Drugs? – GoHealth, accessed August 14, 2025, https://www.gohealth.com/medicare/coverages-benefits/medication-and-prescription-drugs/how-to-save-on-prescriptions/
6. GoodRx: Prescription Prices, Coupons & Pharmacy Information, accessed August 14, 2025, https://www.goodrx.com/
7. Best Prescription Discount Cards of 2025 – SeniorLiving.org, accessed August 14, 2025, https://www.seniorliving.org/prescription-discount-cards/best/
8. How Prescription Discount Cards Work | ScriptSave WellRx, accessed August 14, 2025, https://www.wellrx.com/how-prescription-discount-cards-work/
9. How do Prescription Discount Cards Work? An Honest Look – Community Pharmacy, accessed August 14, 2025, https://communitypharmacy.com/2021/06/how-do-prescription-discount-cards-work/
10. Comparing Prescription Drugs in the U.S. and Other Countries: Prices and Availability, accessed August 14, 2025, https://aspe.hhs.gov/reports/comparing-prescription-drugs
11. Prescription Drug Spending: Why Is the U.S. an Outlier? – Commonwealth Fund, accessed August 14, 2025, https://www.commonwealthfund.org/publications/issue-briefs/2017/oct/paying-prescription-drugs-around-world-why-us-outlier
12. Why Are Prescription Drugs More Expensive in the U.S. than in Other Countries? – GoodRx, accessed August 14, 2025, https://www.goodrx.com/drugs/savings/why-are-prescription-drugs-more-expensive-in-the-us-than-in-other-countries
13. Why are our medicines so expensive? Spoiler: Not for the reasons you are being told, accessed August 14, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10836477/
14. Drug Costs and Their Impact on Care | Arnold Ventures, accessed August 14, 2025, https://www.arnoldventures.org/stories/drug-costs-and-their-impact-on-care
15. Your Stories | TruthinRx, accessed August 14, 2025, https://truthinrx.org/your-stories
16. Insurance denied Pennsylvania man cancer medication. Here’s how he still got it., accessed August 14, 2025, https://www.cbsnews.com/philadelphia/news/insurance-denial-cancer-medication-pennsylvania/
17. Prior Authorization | AMCP.org, accessed August 14, 2025, https://www.amcp.org/concepts-managed-care-pharmacy/prior-authorization
18. What Is Prior Authorization? A Look at the Process and Tips For Approval – GoodRx, accessed August 14, 2025, https://www.goodrx.com/insurance/health-insurance/prior-authorization-what-you-need-to-know
19. Denied – Mended Hearts, accessed August 14, 2025, https://mendedhearts.org/story/denied/
20. Prior Authorization for Pharmacy Drugs – Humana’s provider, accessed August 14, 2025, https://provider.humana.com/pharmacy-resources/prior-authorizations
21. ‘Insurance Just Keeps Getting Worse’: This Texas Doctor Went Viral After Detailing Negative Experience With Giant Health Insurer — All While Operating on a Patient. Here Are 3 Big Takeaways – Moneywise, accessed August 14, 2025, https://moneywise.com/insurance/health/this-texas-doctor-went-viral-after-detailing-negative-experience-with-giant-health-insurer
22. Appealing denails of coverage | MyHealthcareFinances, accessed August 14, 2025, https://www.myhealthcarefinances.com/health-insurance/appealing-denails-of-coverage
23. How to appeal an insurance company decision | HealthCare.gov, accessed August 14, 2025, https://www.healthcare.gov/appeal-insurance-company-decision/
24. Steps to Appeal a Health Insurance Claim Denial – Carefirst BlueCross BlueShield, accessed August 14, 2025, https://individual.carefirst.com/individuals-families/health-insurance-basics/health-insurance-costs/steps-to-appeal-claim-denial.page
25. Health Insurance – How to Appeal a Denied Claim, accessed August 14, 2025, https://www.opic.texas.gov/health-insurance/get-help/appeal-denied-claim/
26. Novo Nordisk Patient Assistance Program (PAP) | NovoCare®, accessed August 14, 2025, https://www.novocare.com/diabetes/help-with-costs/pap.html
27. Eligibility and Enrollment for Uninsured Patients | GSKPAF, accessed August 14, 2025, https://gskpaf.org/gsk/prescription-medicine-patient-assistance/uninsured/
28. Patient Assistance | AbbVie, accessed August 14, 2025, https://www.abbvie.com/patients/patient-support/patient-assistance.html
29. How to Buy Medicines Safely From an Online Pharmacy | FDA, accessed August 14, 2025, https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy
30. Know the signs of a safe online pharmacy – Reginfo.gov, accessed August 14, 2025, https://www.reginfo.gov/public/do/DownloadDocument?objectID=91687601
31. Internet Drug Outlet Identification Program | NABP, accessed August 14, 2025, https://nabp.pharmacy/wp-content/uploads/2016/08/Internet-Drug-Outlet-Report-August-2017.pdf
32. Internet Pharmacy Warning Letters – FDA, accessed August 14, 2025, https://www.fda.gov/drugs/drug-supply-chain-integrity/internet-pharmacy-warning-letters
33. Buying Medicines Online: Safety – Content – Health Encyclopedia …, accessed August 14, 2025, https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=34&contentid=16406-3
34. Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet, accessed August 14, 2025, https://www.ahdbonline.com/issues/2021/march-2021-vol-14-no-1/3086-negative-consequences-of-the-widespread-and-inappropriate-easy-access-to-purchasing-prescription-medications-on-the-internet
35. Survey reveals 9% of people with long-term health conditions cannot afford to collect their prescriptions – The Pharmaceutical Journal, accessed August 14, 2025, https://pharmaceutical-journal.com/article/news/survey-reveals-9-of-people-with-long-term-health-conditions-cannot-afford-to-collect-their-prescriptions
36. Prescription charges are a barrier to keeping people well and in work, survey reveals, accessed August 14, 2025, https://www.parkinsons.org.uk/news/prescription-charges-are-barrier-keeping-people-well-and-work-survey-reveals
37. Podcast 153 – The Cost of Prescription Medicines in Australia | – Slow English, accessed August 14, 2025, https://slowenglish.info/podcast-153-the-cost-of-prescription-medicines-in-australia/
38. How is the cost of medicines to consumers determined? – HealthyWA, accessed August 14, 2025, https://www.healthywa.wa.gov.au/Articles/F_I/How-is-the-cost-of-medicines-to-consumers-determined
39. Impact of removing prescription charges on health outcomes: protocol for a randomised controlled trial – PubMed Central, accessed August 14, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8728355/
40. New Zealand agency comes under pressure to pay more for drugs | The BMJ, accessed August 14, 2025, https://www.bmj.com/content/342/bmj.d3933